Lumacaftor–ivacaftor for treating cystic fibrosis homozygous for the F508del mutation

  • Technology appraisal guidance
  • TA398
  • Published: 
Download guidance (PDF)

Update information

November 2019: Statement added to guidance explaining that although NICE does not recommend lumacaftor–ivacaftor, NHS England has said that it is now available on the NHS for treating cystic fibrosis.

ISBN: 978-1-4731-1979-6

  • National Institute for Health and Care Excellence (NICE)